AlphAIalphai — Financial news for AI agents
financialcontent.comJUL 295 min read$PBI

Pitney Bowes (NYSE:PBI) Exceeds Q2 CY2026 Expectations

Pitney Bowes (NYSE:PBI) reported Q2 CY2026 revenue of $451.5 million, down 2.3% year on year, but 1.8% above market expectations. Full-year revenue guidance is $1.83 billion at the midpoint, 0.7% below analysts’ estimates. Non-GAAP EPS was $0.43, up 32.3% versus consensus.

Original reporting
financialcontent.com
Published Jul 29, 2026, 10:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 11:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Pitney Bowes (NYSE:PBI) Exceeds Q2 CY2026 Expectations — source image
Source · financialcontent.com
Decision brief

The 30-second read

$PBINeutralMed
01

Why it matters

Traders can use the Q2 beat (adjusted EPS and revenue vs estimates) and the full-year revenue guidance miss to gauge near-term estimate revisions and risk around revenue stabilization, despite improving margins and EPS growth.

02

Market read

Mixed earnings signal: profitability and EPS beat, but full-year revenue guidance slightly under consensus while revenue remains down YoY.

03

What to watch

The article highlights margin expansion and share count shrink, but does not quantify segment mix, backlog, or cash flow, which could determine whether the revenue guidance miss is temporary or structural.

Relevance 7/10Novelty 7/10Timing: after-hours/earnings reaction, with the stock up 2.4% to $18.11 immediately after reporting

Background

Pitney Bowes is a shipping and mailing solutions provider, and the article frames its Q2 CY2026 results versus revenue and EPS expectations plus full-year revenue guidance.

Company-level read

Ticker impact

$PBINeutralMedium confidence
Context

Pitney Bowes reported Q2 CY2026 adjusted EPS of $0.43 and beat revenue estimates, while full-year revenue guidance of $1.83B missed by 0.7% at the midpoint.

Expected impact

Likely supports a modest positive bias post-earnings, but the guidance miss may cap upside and keep focus on revenue stabilization.

Evidence & confidence

The article provides a concrete Q2 beat (EPS and revenue vs estimates) plus a specific full-year revenue guidance shortfall, which typically drives near-term revisions and trading around the earnings print.

Market effects

Sector

Signals ongoing margin discipline in business services/shipping and mailing, even as top-line demand remains pressured.

Regional

No specific regional demand or macro linkage provided in the article.

Global

No explicit global supply chain or international demand drivers cited.

Counterpoint

What could challenge this read

The guidance midpoint is below consensus and revenue is still down year over year, so the EPS outperformance may reflect cost actions that are not yet translating into durable demand recovery.

Key entities

  • company
    Pitney Bowes

    Reported Q2 CY2026 results, including adjusted EPS of $0.43 and full-year revenue guidance of $1.83B at the midpoint.

Read at source← All news

Related articles

AUG 8
$PBIMedAI 8/10

Pitney Bowes (PBI) Q2 2026 Earnings Call Transcript

Pitney Bowes (PBI) reported Q2 2026 revenue of $451 million, down 2%, with adjusted EBIT of $116 million up 13% and adjusted free cash flow of $148 million up 39%. Management raised guidance for adjusted EBIT to $445-$475 million and adjusted EPS to $1.55-$1.70, citing cost actions and a $5 million tariff refund, while Presort faced lower volumes and higher fuel costs.

fool.com6 min
AUG 8
$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

yahoo.com6 min
AUG 8
$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

yahoo.com6 min
AUG 8
$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

yahoo.com6 min
AUG 8
$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

yahoo.com6 min